Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease

Keyphrases

• Parkinson's Disease 100%
• Clinical Outcomes 100%
• Human Embryo 100%
• Cell Survival 100%
• Survival Outcomes 100%
• Intrastriatal Transplantation 100%
• Clinical Trials 66%
• Dopaminergic Neurons 66%
• Embryonic Tissue 66%
• Patient Selection 33%
• Putamen 33%
• Fluorodopa 33%
• Parkinson Patients 33%
• Mesencephalic Tissue 33%
• Graft Survival 33%
• Cell-derived 33%
• Normal Means 33%
• Minimum number 33%
• Reinnervation 33%
• Transplantation 33%
• Volume Density 33%
• Functional Integration 33%
• Favorable Outcome 33%
• Alternative Data Sources 33%
• Clinical Benefit 33%
• Donor Cells 33%
• Neural Transplantation 33%
• Cell Therapy 33%
• Dopamine Release 33%
• Donor Tissue 33%
• Methodology Selection 33%
• Clinical Autopsy 33%
• Autopsy Findings 33%
• Therapeutic Potential 33%

Medicine and Dentistry

• Parkinson's Disease 100%
• Cell Survival 100%
• Dopaminergic Neuron 50%
• Clinical Trial 50%
• Reinnervation 25%
• Fluorine-18 25%
• Dopamine Release 25%
• Graft Survival 25%
• Patient Selection 25%
• Hemisphere 25%
• Putamen 25%
• Cell Therapy 25%
• Human Embryo 25%
• Mesencephalic Tissue 25%

Neuroscience

• Parkinson's Disease 100%
• Cell Survival 100%
• Dopaminergic Neuron 50%
• Fluorodopa 25%
• Putamen 25%
• Fluorine-18 25%
• Reinnervation 25%
• Cell Therapy 25%
• Dopamine Release 25%